Abstract
The aim of this work was to investigate the antimicrobial properties of thyme essential oil against clinical multiresistant strains of Acinetobacter spp. The antibacterial activity of oil was tested against standard and clinical bacterial strains of Acinetobacter genus. The agar diffusion method was used to check the inhibition of microbial growth at various concentrations of the oil from Thymus vulgaris. Susceptibility testing to antibiotics and chemotherapeutics was prepared using the disc-diffusion method. Identification of bacterial strains was carried out with the Vitek system and confirmed by PCR for Acinetobacter baumanii gyrB gene. The results of experiments showed that the oil from T. vulgaris exhibited an extremely strong activity against all of the clinical strains of Acinetobacter. Thyme oil demonstrated a very good efficacy against multiresistant strains of tested bacteria. Essential oils seems to be an excellent alternative for synthetic preparations and that is reason for an extensive assessment of their antimicrobial activity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Chastre J., Evolving problems with resistant pathogens, Clin. Microbiol. Infect., 2008, 14, 3–14
Kalemba D., Kunicka A., Antibacterial and antifungal properties of essential oils, Curr. Med. Chem., 2003, 10, 813–829
Giordani R., Regli P., Kaloustian J., Portugal H., Potentation of antifungal activity of amphoteracin B by essential oil from Cinnamonium cassia, Phytother. Res., 2006, 20, 58–61
Lis-Balchin M., Deans S., Hart S., Bioactive Geranium oils from different commercial sources, J. Essent. Oil Res., 2007, 8, 281–290
Rosato A., Vitali C., De Laurentis N., Armenise D., Antonietta Milillo M., Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin, Phytomedicine, 2007, 14, 727–732
Shin S., Kim J., In vitro inhibitory activities of essential oils from two Korean Thymus species against antibiotic-resistant pathogens, Arch. Pharm. Res., 2005, 28, 897–901
King L., Swiatlo E., Swiatlo A., Swiatlo A., McDaniel L.S., Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii, FEMS Immunol. Med. Microbiol., 2009, 55, 414–421
Gaynes R., Edwards J., Overview of nosocomial infections caused by gram-negative bacilli, Clin. Infect. Dis., 2005, 41, 848–854
Falagas M., Karveli E., The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications, Clin. Microbiol. Infect., 2007, 13, 117–119
Bernabeu-Wittel M., Pichardo C., Garcia-Curiel A., Pachón-Ibáñez M., Ibáñez-MartÍnez J., Jimenez-Mejias M., et al., Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia, Clin. Microbiol. Infect., 2005, 11, 319–325
Ecker J., Massire C., Hall T., Ranken R., Penella T., Agasino Ivy C., et al., Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry, J. Clin. Microbiol., 2006, 44, 2921–2932
Wisplinghoff H., Edmond M., Pfaller M., Jones R., Wenzel R., Seifert H., Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility, Clin. Infect. Dis., 2000, 31, 690–697
Higgins P., Wisplinghoff H., Krut O., Seifert A., PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU, Clin. Microbiol. Infect., 2007, 13, 1199–1201
Adams R.P., Identification of essential oil components by gas chromatography/mass spectroscopy, 4th Ed., Allured Publishing Corporation, Carol Stream, IL, USA, 2007
Joulain D., König W.A., The atlas of spectral data of sesquiterpene hydrocarbons, E.B.-Verlag, Hamburg, 1998
Clinical and Laboratory Standard Institute (CLSI), Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. CLSI document M100-S16, Clinical and Laboratory Standard Institute, Wayne, Pennsylvania, USA, 2006
Polish Pharmacopeia, 8th Ed., Polish Pharmaceutical Society, Warsaw, 2008
European Pharmacopoeia, 6th Ed., Council of Europe, Strasbourg, 2008
Ye J.-J., Huang C.-T., Shie S.-S., Huang P.-Y., Su L.-H., Chiu C.H., Multidrug resistant Acinetobacter baumannii: Risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains, PLoS ONE, 2010, 5, e9947
Lis-Balchin M., Aromatherapy Science. A guide for healthcare professionals, 2nd Ed., Pharmaceutical Press, London, 2006
Price A., Price L., Aromatherapy for health professionals, 3rd Ed., Churchill Livingstone, London 1999
Routsi C., Pratikaki M., Platsouka E., Sotiropoulou C., Nanas S., Markaki V., et al., Carbapenemresistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes, Infection, 2010, 38, 173–180
Chastre J., Wolff M., Fagon J., Chevret S., Thomas F., Wermert D., et al., Comparison of 8 vs 15 days of antibiotic therapy for ventilatorassociated pneumonia in adults: a randomized trial, J. Am. Med. Assoc., 2003, 290, 2588–2598
Meyer E., Schwab F., Schroeren-Boersch B., Gastmeier P., Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008, Crit. Care, 2010, 14, R113–R121
Dent L., Marshall D., Pratap S., Hulette R., Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital, BMC Infect. Dis., 2010, 10, e196
Falagas M., Koletsi P., Bliziotis I., The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa, J. Med. Microbiol., 2006, 55, 1615–1617
Fabio A., Cermelli C., Fabio G., Nicoletti P., Quaglio P., Screening of the antibacterial effects of a variety of essential oils on microorganisms responsible for respiratory infections, Phytother. Res., 2007, 21, 374–377
Bekhechi C., Bekkara F.A., Abdelouahid D.E., Tomi F., Casanova J., Composition and Antibacterial Activity of the Essential Oil of Thymus fotanesii Boiss. et Reut. from Algeria, J. Essent. Oil Res., 2007, 19, 594–596
Rosooli I., Mirmostafa S., Bacterial susceptibility to and chemical composition of essential oils from Thymus kotschyanus and Thymus persicus, J. Agr. Food Chem., 2003, 51, 2200–2205
Coelho da Costa A., Cavalcanti dos Santos B., Filho L., de Oliveira Lima E., Antibacterial activity of the essential oil of Origanum vulgare L. (Lamiaceae) against bacterial multiresistant strains isolated from nosocomial patients, Rev. Brasil. Farmacogn., 2009, 19, 236–241
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Łysakowska, M., Denys, A. & Sienkiewicz, M. The activity of thyme essential oil against Acinetobacter spp.. cent.eur.j.biol. 6, 405–413 (2011). https://doi.org/10.2478/s11535-011-0008-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11535-011-0008-x